BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boyer TD, Haskal ZJ;  American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology. 2005;41:386-400. [PMID: 15660434 DOI: 10.1002/hep.20559] [Cited by in Crossref: 286] [Cited by in F6Publishing: 215] [Article Influence: 17.9] [Reference Citation Analysis]
Number Citing Articles
1 Shaked O, Reddy KR. Approach to a Liver Mass. Clinics in Liver Disease 2009;13:193-210. [DOI: 10.1016/j.cld.2009.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
2 Jalaeian H, Talaie R, D'Souza D, Taleb S, Noorbaloochi S, Flanagan S, Hunter D, Golzarian J. Minilaparotomy-Assisted Transmesenteric-Transjugular Intrahepatic Portosystemic Shunt: Comparison with Conventional Transjugular Approach. Cardiovasc Intervent Radiol 2016;39:1413-9. [PMID: 27272888 DOI: 10.1007/s00270-016-1385-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
3 Dufour DR. Liver Disease. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Elsevier; 2012. pp. 1637-93. [DOI: 10.1016/b978-1-4160-6164-9.00050-0] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 King A, Masterton G, Gunson B, Olliff S, Redhead D, Mangat K, Oniscu G, Hayes P, Tripathi D. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation: Tips in Liver Transplant Recipients. Liver Transpl 2011;17:771-8. [DOI: 10.1002/lt.22281] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
5 Kim HK, Kim YJ, Chung WJ, Kim SS, Shim JJ, Choi MS, Kim DY, Jun DW, Um SH, Park SJ, Woo HY, Jung YK, Baik SK, Kim MY, Park SY, Lee JM, Kim YS. Clinical outcomes of transjugular intrahepatic portosystemic shunt for portal hypertension: Korean multicenter real-practice data. Clin Mol Hepatol 2014;20:18-27. [PMID: 24757655 DOI: 10.3350/cmh.2014.20.1.18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
6 Cárdenas A, Arroyo V. Refractory ascites. Dig Dis. 2005;23:30-38. [PMID: 15920323 DOI: 10.1159/000084723] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
7 Lo GH. Management of acute esophageal variceal hemorrhage. Kaohsiung J Med Sci. 2010;26:55-67. [PMID: 20123593 DOI: 10.1016/s1607-551x(10)70009-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
8 Huang M, Feng Z, Ji D, Cao Y, Shi X, Chen P, Wang P, Tang M, Liu K. Use of a transjugular intrahepatic portosystemic shunt combined with autologous bone marrow cell infusion in patients with decompensated liver cirrhosis: an exploratory study. Cytotherapy. 2014;16:1575-1583. [PMID: 25287603 DOI: 10.1016/j.jcyt.2014.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Gjeorgjievski M, Cappell MS. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy. World J Hepatol. 2016;8:231-262. [PMID: 26855694 DOI: 10.4254/wjh.v8.i4.231] [Cited by in Crossref: 36] [Cited by in F6Publishing: 21] [Article Influence: 7.2] [Reference Citation Analysis]
10 Di Giorgio A, Agazzi R, Alberti D, Colledan M, D’antiga L. Feasibility and Efficacy of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Children. Journal of Pediatric Gastroenterology & Nutrition 2012;54:594-600. [DOI: 10.1097/mpg.0b013e3182490c05] [Cited by in Crossref: 43] [Cited by in F6Publishing: 5] [Article Influence: 4.8] [Reference Citation Analysis]
11 Pereira K, Carrion AF, Martin P, Vaheesan K, Salsamendi J, Doshi M, Yrizarry JM. Current diagnosis and management of post-transjugular intrahepatic portosystemic shunt refractory hepatic encephalopathy. Liver Int. 2015;35:2487-2494. [PMID: 26332169 DOI: 10.1111/liv.12956] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
12 Senzolo M, Germani G, Cholongitas E, Burra P, Burroughs AK. Veno occlusive disease: update on clinical management. World J Gastroenterol 2007;13:3918-24. [PMID: 17663504 DOI: 10.3748/wjg.v13.i29.3918] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 35] [Article Influence: 4.1] [Reference Citation Analysis]
13 Jairath V, Rehal S, Logan R, Kahan B, Hearnshaw S, Stanworth S, Travis S, Murphy M, Palmer K, Burroughs A. Acute variceal haemorrhage in the United Kingdom: Patient characteristics, management and outcomes in a nationwide audit. Digestive and Liver Disease 2014;46:419-26. [DOI: 10.1016/j.dld.2013.12.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
14 Cárdenas A, Ginès P. Therapy insight: Management of hepatorenal syndrome. Nat Clin Pract Gastroenterol Hepatol. 2006;3:338-348. [PMID: 16741553 DOI: 10.1038/ncpgasthep0517] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
15 Riggio O, Ridola L, Lucidi C, Angeloni S. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for management of portal hypertension: time to update the guidelines? Dig Liver Dis. 2010;42:462-467. [PMID: 20036625 DOI: 10.1016/j.dld.2009.11.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
16 Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W;  Practice Guidelines Committee of the American Association for the Study of Liver Diseases;  Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007;46:922-938. [PMID: 17879356 DOI: 10.1002/hep.21907] [Cited by in Crossref: 1135] [Cited by in F6Publishing: 838] [Article Influence: 81.1] [Reference Citation Analysis]
17 Eldorry A, Barakat E, Abdella H, Abdelhakam S, Shaker M, Hamed A, Sakr M. Outcome of non surgical hepatic decompression procedures in Egyptian patients with Budd-Chiari. World J Gastroenterol. 2011;17:906-913. [PMID: 21412499 DOI: 10.3748/wjg.v17.i7.906] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
18 Boyer TD. Clinical trials for variceal bleeding: And the winner is-The patient: Editorial. Liver Transpl 2007;13:1212-3. [DOI: 10.1002/lt.21122] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
19 Dhanasekaran R, West JK, Gonzales PC, Subramanian R, Parekh S, Spivey JR, Martin LG, Kim HS. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis. Am J Gastroenterol. 2010;105:635-641. [PMID: 19904245 DOI: 10.1038/ajg.2009.634] [Cited by in Crossref: 93] [Cited by in F6Publishing: 60] [Article Influence: 7.8] [Reference Citation Analysis]
20 Solà E, Sanchez-Cabús S, Rodriguez E, Elia C, Cela R, Moreira R, Pose E, Sánchez-Delgado J, Cañete N, Morales-Ruiz M, Campos F, Balust J, Guevara M, García-Valdecasas JC, Ginès P. Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites. Liver Transpl 2017;23:583-93. [PMID: 28318147 DOI: 10.1002/lt.24763] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
21 Dhiman RK, Chawla YK. Minimal hepatic encephalopathy. Indian J Gastroenterol. 2009;28:5-16. [PMID: 19529896 DOI: 10.1007/s12664-009-0003-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 5.3] [Reference Citation Analysis]
22 Biecker E. Diagnosis and therapy of ascites in liver cirrhosis. World J Gastroenterol 2011;17:1237-48. [PMID: 21455322 DOI: 10.3748/wjg.v17.i10.1237] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
23 Garcia-Tsao G, Lim JK; Members of Veterans Affairs Hepatitis C Resource Center Program. Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Am J Gastroenterol. 2009;104:1802-1829. [PMID: 19455106 DOI: 10.1038/ajg.2009.191] [Cited by in Crossref: 168] [Cited by in F6Publishing: 139] [Article Influence: 14.0] [Reference Citation Analysis]
24 Leevy CB, Phillips JA. Hospitalizations during the use of rifaximin versus lactulose for the treatment of hepatic encephalopathy. Dig Dis Sci. 2007;52:737-741. [PMID: 17245628 DOI: 10.1007/s10620-006-9442-4] [Cited by in Crossref: 111] [Cited by in F6Publishing: 87] [Article Influence: 7.9] [Reference Citation Analysis]
25 Ilovitsh T, Ilovitsh A, Foiret J, Ferrara KW. Imaging beyond ultrasonically-impenetrable objects. Sci Rep 2018;8:5759. [PMID: 29636513 DOI: 10.1038/s41598-018-23776-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
26 Bai M, Qi XS, Yang ZP, Yang M, Fan DM, Han GH. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis. World J Gastroenterol. 2014;20:2704-2714. [PMID: 24627607 DOI: 10.3748/wjg.v20.i10.2704] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
27 Qi X, Dai J, Yang M, Ren W, Jia J, Guo X. Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature. Gastroenterol Res Pract. 2015;2015:480842. [PMID: 25810714 DOI: 10.1155/2015/480842] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
28 Senzolo M, Burra P, Cholongitas E, Lodato F, Marelli L, Manousou P, Patch D, Sturniolo GC, Burroughs AK. The transjugular route: the key hole to the liver world. Dig Liver Dis. 2007;39:105-116. [PMID: 17196894 DOI: 10.1016/j.dld.2006.06.038] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
29 Munoz SJ. Hepatic encephalopathy. Med Clin North Am. 2008;92:795-812, viii. [PMID: 18570943 DOI: 10.1016/j.mcna.2008.03.009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
30 Qi X, Tian Y, Zhang W, Yang Z, Guo X. Covered versus bare stents for transjugular intrahepatic portosystemic shunt: an updated meta-analysis of randomized controlled trials. Therap Adv Gastroenterol 2017;10:32-41. [PMID: 28286557 DOI: 10.1177/1756283X16671286] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
31 Cremers I, Ribeiro S. Management of variceal and nonvariceal upper gastrointestinal bleeding in patients with cirrhosis. Therap Adv Gastroenterol. 2014;7:206-216. [PMID: 25177367 DOI: 10.1177/1756283x14538688] [Cited by in Crossref: 28] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
32 Wong F. The use of TIPS in chronic liver disease. Annals of Hepatology 2006;5:5-15. [DOI: 10.1016/s1665-2681(19)32033-2] [Cited by in Crossref: 29] [Article Influence: 1.9] [Reference Citation Analysis]
33 Buscaglia JM, Dray X, Shin EJ, Magno P, Chmura KM, Surti VC, Dillon TE, Ducharme RW, Donatelli G, Thuluvath PJ. A new alternative for a transjugular intrahepatic portosystemic shunt: EUS-guided creation of an intrahepatic portosystemic shunt (with video). Gastrointest Endosc. 2009;69:941-947. [PMID: 19327481 DOI: 10.1016/j.gie.2008.09.051] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
34 Kanwal F, Kramer J, Asch SM, El-Serag H, Spiegel BM, Edmundowicz S, Sanyal AJ, Dominitz JA, McQuaid KR, Martin P, Keeffe EB, Friedman LS, Ho SB, Durazo F, Bacon BR. An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. Clin Gastroenterol Hepatol. 2010;8:709-717. [PMID: 20385251 DOI: 10.1016/j.cgh.2010.03.028] [Cited by in Crossref: 91] [Cited by in F6Publishing: 76] [Article Influence: 8.3] [Reference Citation Analysis]
35 Liu L, Zhao Y, Qi X, Cai G, He C, Guo W, Yin Z, Chen H, Chen X, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis. Hepatol Res. 2014;44:621-630. [PMID: 23679937 DOI: 10.1111/hepr.12162] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
36 Harding DJ, Perera MT, Chen F, Olliff S, Tripathi D. Portal vein thrombosis in cirrhosis: Controversies and latest developments. World J Gastroenterol. 2015;21:6769-6784. [PMID: 26078553 DOI: 10.3748/wjg.v21.i22.6769] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 27] [Article Influence: 9.2] [Reference Citation Analysis]
37 Zheng G, Zhang LJ, Cao Y, Pan Z, Qi RF, Ni L, Shi D, Fan X, Lu GM. Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study. Metab Brain Dis. 2013;28:463-471. [PMID: 23564221 DOI: 10.1007/s11011-013-9400-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
38 Bai M, Qi XS, Yang ZP, Wu KC, Fan DM, Han GH. EVS vs TIPS shunt for gastric variceal bleeding in patients with cirrhosis: A meta-analysis. World J Gastrointest Pharmacol Ther 2014;5:97-104. [PMID: 24868490 DOI: 10.4292/wjgpt.v5.i2.97] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
39 Naeshiro N, Aikata H, Kakizawa H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Ohno A, Miyaki D, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Awai K, Chayama K. Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol 2014;29:1035-42. [PMID: 24372807 DOI: 10.1111/jgh.12508] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
40 Holecek M. Ammonia and amino acid profiles in liver cirrhosis: Effects of variables leading to hepatic encephalopathy. Nutrition 2015;31:14-20. [DOI: 10.1016/j.nut.2014.03.016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 9.7] [Reference Citation Analysis]
41 Rosemurgy A, Thometz D, Clark W, Villadolid D, Carey E, Pinkas D, Rakita S, Zervos E. Survival and variceal rehemorrhage after shunting support small-diameter prosthetic H-graft portacaval shunt. J Gastrointest Surg 2007;11:325-32. [PMID: 17458606 DOI: 10.1007/s11605-006-0056-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Tsauo J, Tie J, Xue H, Zhao JB, Li JJ, Fang ZT, Guo WH, Li X. Transjugular Intrahepatic Portosystemic Shunt Creation for the Prevention of Gastric Variceal Rebleeding in Patients with Hepatocellular Carcinoma: A Multicenter Retrospective Study. J Vasc Interv Radiol 2021;32:963-9. [PMID: 33864909 DOI: 10.1016/j.jvir.2021.04.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Heinzow HS, Lenz P, Köhler M, Reinecke F, Ullerich H, Domschke W, Domagk D, Meister T. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis. World J Gastroenterol. 2012;18:5211-5218. [PMID: 23066315 DOI: 10.3748/wjg.v18.i37.5211] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
44 Heller J, Sauerbruch T. Prevention of recurrent haemorrhage. Best Practice & Research Clinical Gastroenterology 2007;21:43-53. [DOI: 10.1016/j.bpg.2006.07.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
45 Kim JJ, Dasika NL, Yu E, Fontana RJ. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: TIPS following liver transplantation. Liver International 2008;28:240-8. [DOI: 10.1111/j.1478-3231.2007.01645.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
46 Gaba RC. Transjugular Intrahepatic Portosystemic Shunt Creation With Embolization or Obliteration for Variceal Bleeding. Techniques in Vascular and Interventional Radiology 2016;19:21-35. [DOI: 10.1053/j.tvir.2016.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
47 Runyon BA;  AASLD Practice Guidelines Committee. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49:2087-2107. [PMID: 19475696 DOI: 10.1002/hep.22853] [Cited by in Crossref: 567] [Cited by in F6Publishing: 407] [Article Influence: 47.3] [Reference Citation Analysis]
48 Dhanasekaran R, Gonzales P, West J, Subramanian R, Parekh S, Spivey JR, Reshamwala P, Martin LG, Kim HS. Predictors of early mortality post transjugular intrahepatic portosystemic shunts and the role of hepatic venous pressure gradient. Gastrointestinal Intervention 2012;1:63-8. [DOI: 10.1016/j.gii.2012.08.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
49 Shukla A, Shreshtha A, Mukund A, Bihari C, Eapen CE, Han G, Deshmukh H, Cua IHY, Lesmana CRA, Al Meshtab M, Kage M, Chaiteeraki R, Treeprasertsuk S, Giri S, Punamiya S, Paradis V, Qi X, Sugawara Y, Abbas Z, Sarin SK. Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2021;15:531-67. [PMID: 34240318 DOI: 10.1007/s12072-021-10189-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Preibsch H, Spira D, Thaiss WM, Syha R, Nikolaou K, Ketelsen D, Lauer UM, Horger M. Impact of transjugular intrahepatic portosystemic shunt implantation on liver perfusion measured by volume perfusion CT. Acta Radiol. 2017;58:1167-1173. [PMID: 28084812 DOI: 10.1177/0284185116685922] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
51 Biecker E, Roth F, Heller J, Schild HH, Sauerbruch T, Schepke M. Prognostic role of the initial portal pressure gradient reduction after TIPS in patients with cirrhosis. Eur J Gastroenterol Hepatol. 2007;19:846-852. [PMID: 17873607 DOI: 10.1097/meg.0b013e3282eeb488] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
52 Weilert F, Binmoeller KF. Endoscopic management of gastric variceal bleeding. Gastroenterol Clin North Am. 2014;43:807-818. [PMID: 25440927 DOI: 10.1016/j.gtc.2014.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
53 Hayek G, Ronot M, Plessier A, Sibert A, Abdel-Rehim M, Zappa M, Rautou PE, Valla D, Vilgrain V. Long-term Outcome and Analysis of Dysfunction of Transjugular Intrahepatic Portosystemic Shunt Placement in Chronic Primary Budd-Chiari Syndrome. Radiology. 2017;283:280-292. [PMID: 27797679 DOI: 10.1148/radiol.2016152641] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 6.6] [Reference Citation Analysis]
54 Liu J, Shi Q, Xiao S, Zhou C, Zhou B, Yuan F, Zheng C, Lin S, Qian K, Feng G, Xiong B. Using transjugular intrahepatic portosystemic shunt as the first-line therapy in secondary prophylaxis of variceal hemorrhage. J Gastroenterol Hepatol 2020;35:278-83. [PMID: 31222830 DOI: 10.1111/jgh.14761] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Xiao L, Li F, Wei B, Li B, Tang CW. Small-for-size syndrome after living donor liver transplantation: successful treatment with a transjugular intrahepatic portosystemic shunt. Liver Transpl. 2012;18:1118-1120. [PMID: 22511462 DOI: 10.1002/lt.23457] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
56 van Erpecum KJ. Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis. Scand J Gastroenterol Suppl. 2006;79-84. [PMID: 16782626 DOI: 10.1080/00365520600664342] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
57 Chen S, Li X, Wei B, Tong H, Zhang MG, Huang ZY, Cao JW, Tang CW. Recurrent variceal bleeding and shunt patency: prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization. Radiology. 2013;268:900-906. [PMID: 23657891 DOI: 10.1148/radiol.13120800] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
58 Zhang H, Zhang H, Li H, Zhang H, Zheng D, Sun CM, Wu J. TIPS versus endoscopic therapy for variceal rebleeding in cirrhosis: A meta-analysis update. J Huazhong Univ Sci Technolog Med Sci 2017;37:475-85. [PMID: 28786052 DOI: 10.1007/s11596-017-1760-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Henderson JM, Boyer TD, Kutner MH, Galloway JR, Rikkers LF, Jeffers LJ, Abu-Elmagd K, Connor J; DIVERT Study Group. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial. Gastroenterology. 2006;130:1643-1651. [PMID: 16697728 DOI: 10.1053/j.gastro.2006.02.008] [Cited by in Crossref: 176] [Cited by in F6Publishing: 106] [Article Influence: 11.7] [Reference Citation Analysis]
60 Khungar V, Poordad F. Management of overt hepatic encephalopathy. Clin Liver Dis. 2012;16:73-89. [PMID: 22321466 DOI: 10.1016/j.cld.2012.03.009] [Cited by in Crossref: 44] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
61 Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ. Randomized trial of emergency endoscopic sclerotherapy versus emergency portacaval shunt for acutely bleeding esophageal varices in cirrhosis. J Am Coll Surg. 2009;209:25-40. [PMID: 19651060 DOI: 10.1016/j.jamcollsurg.2009.02.059] [Cited by in Crossref: 43] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
62 Ahuja NK, Ally WA, Caldwell SH. Direct acting inhibitors of ammoniagenesis: a role in post-TIPS encephalopathy? Annals of Hepatology 2014;13:179-86. [DOI: 10.1016/s1665-2681(19)30880-4] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
63 Pezzoli A, Fusetti N, Simone L, Zelante A, Cifalà V, Carella A, Gullini S. Portal hypertensive enteropathy diagnosed by capsule endoscopy and demonstration of the ileal changes after transjugular intrahepatic portosystemic shunt placement: a case report. J Med Case Rep 2011;5:90. [PMID: 21371340 DOI: 10.1186/1752-1947-5-90] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Hiraga N, Aikata H, Takaki S, Kodama H, Shirakawa H, Imamura M, Kawakami Y, Takahashi S, Toyota N, Ito K, Tanaka S, Kitamoto M, Chayama K. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol 2007;42:663-72. [DOI: 10.1007/s00535-007-2077-1] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 4.8] [Reference Citation Analysis]
65 Novelli PM, Cho K, Rubin JM. Sonographic Assessment of Spleen Stiffness Before and After Transjugular Intrahepatic Portosystemic Shunt Placement With or Without Concurrent Embolization of Portal Systemic Collateral Veins in Patients With Cirrhosis and Portal Hypertension: A Feasibility Study. Journal of Ultrasound in Medicine 2015;34:443-9. [DOI: 10.7863/ultra.34.3.443] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
66 Weilert F, Binmoeller KF. EUS-Guided Vascular Access and Therapy. Gastrointestinal Endoscopy Clinics of North America 2012;22:303-14. [DOI: 10.1016/j.giec.2012.04.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
67 Qi X, Han G, Yin Z, He C, Wang J, Guo W, Niu J, Zhang W, Bai M, Fan D. Transjugular intrahepatic portosystemic shunt for portal cavernoma with symptomatic portal hypertension in non-cirrhotic patients. Dig Dis Sci. 2012;57:1072-1082. [PMID: 22147244 DOI: 10.1007/s10620-011-1975-5] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
68 Cazzaniga M, Salerno F, Pagnozzi G, Dionigi E, Visentin S, Cirello I, Meregaglia D, Nicolini A. Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt. Gut. 2007;56:869-875. [PMID: 17135305 DOI: 10.1136/gut.2006.102467] [Cited by in Crossref: 144] [Cited by in F6Publishing: 110] [Article Influence: 9.6] [Reference Citation Analysis]
69 Solà E, Solé C, Ginès P. Management of uninfected and infected ascites in cirrhosis. Liver Int 2016;36 Suppl 1:109-15. [PMID: 26725907 DOI: 10.1111/liv.13015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
70 Gitto S, Vizzutti F, Schepis F, Turco L, Aspite S, Vitale G, Arena U, Villa E, Laffi G, Debernardi-Venon W, Fanelli F, Andreone P, Marra F; DAA-TIPS group. Transjugular Intrahepatic Portosystemic Shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: A real-life, case-control study. Dig Liver Dis 2019;51:870-4. [PMID: 30824409 DOI: 10.1016/j.dld.2018.11.015] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
71 Bai M, Han G, Qi X, Yin Z, Fan D. Two hypotheses for decreasing hepatic encephalopathy risk after transjugular intrahepatic portosystemic shunt. Hepatology 2010;51:2236-7. [DOI: 10.1002/hep.23493] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
72 Anand R, Ali SE, Raissi D, Frandah WM. Duodenal variceal bleeding with large spontaneous portosystemic shunt treated with transjugular intrahepatic portosystemic shunt and embolization: A case report. World J Radiol 2019;11:110-5. [PMID: 31523400 DOI: 10.4329/wjr.v11.i8.110] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
73 Al-khafaji A, Nadim MK, Kellum JA. Hepatorenal Disorders. Chest 2015;148:550-8. [DOI: 10.1378/chest.14-1925] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
74 Møller S, Bendtsen F. Cirrhotic Multiorgan Syndrome. Dig Dis Sci 2015;60:3209-25. [DOI: 10.1007/s10620-015-3752-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
75 Cárdenas A, Arroyo V. Management of ascites and hepatic hydrothorax. Best Pract Res Clin Gastroenterol. 2007;21:55-75. [PMID: 17223497 DOI: 10.1016/j.bpg.2006.07.012] [Cited by in Crossref: 30] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
76 Garcia-tsao G. Ascites. Zakim and Boyer's Hepatology. Elsevier; 2012. pp. 283-95. [DOI: 10.1016/b978-1-4377-0881-3.00018-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Björnsson E, Björnsson E, Aabakken L, Olafsson S, Bendtsen F. Are specific guidelines necessary for treatment of esophageal varices in the Nordic countries? Scandinavian Journal of Gastroenterology 2009;44:1037-47. [DOI: 10.1080/00365520903075170] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
78 Boyer TD. Transjugular intrahepatic portosystemic shunt in the management of complications of portal hypertension. Curr Gastroenterol Rep 2008;10:30-5. [DOI: 10.1007/s11894-008-0006-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
79 European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53:397-417. [PMID: 20633946 DOI: 10.1016/j.jhep.2010.05.004] [Cited by in Crossref: 1002] [Cited by in F6Publishing: 762] [Article Influence: 91.1] [Reference Citation Analysis]
80 Vizzutti F, Schepis F, Arena U, Fanelli F, Gitto S, Aspite S, Turco L, Dragoni G, Laffi G, Marra F. Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes. Intern Emerg Med 2020;15:37-48. [DOI: 10.1007/s11739-019-02252-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
81 Rostambeigi N, Farsad K, Young S, Shrestha P, Jahangiri Y, Liang KW, Cretcher M, Golzarian J. Lower-Extremity Edema Is Common after Transjugular Intrahepatic Portosystemic Shunt Creation and Is Associated with Lower Survival: A Two-Institution Study. Radiology 2021;298:221-7. [PMID: 33201792 DOI: 10.1148/radiol.2020201690] [Reference Citation Analysis]
82 Garcia–pagán JC, Heydtmann M, Raffa S, Plessier A, Murad S, Fabris F, Vizzini G, Abraldes JG, Olliff S, Nicolini A, Luca A, Primignani M, Janssen HL, Valla D, Elias E, Bosch J. TIPS for Budd-Chiari Syndrome: Long-Term Results and Prognostics Factors in 124 Patients. Gastroenterology 2008;135:808-15. [DOI: 10.1053/j.gastro.2008.05.051] [Cited by in Crossref: 227] [Cited by in F6Publishing: 147] [Article Influence: 17.5] [Reference Citation Analysis]
83 Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: evidence based treatment. World J Gastroenterol. 2014;20:5442-5460. [PMID: 24833875 DOI: 10.3748/wjg.v20.i18.5442] [Cited by in CrossRef: 87] [Cited by in F6Publishing: 66] [Article Influence: 14.5] [Reference Citation Analysis]
84 Garcia-tsao G. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites. Nat Rev Gastroenterol Hepatol 2006;3:380-9. [DOI: 10.1038/ncpgasthep0523] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
85 Yue-Meng W, Li YH, Wu HM, Yang J, Yang LH, Xu Y. Portal Vein Thrombosis in Patients With Cirrhosis Undergoing Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors, Warfarin Efficacy, and Clinical Outcomes. Clin Appl Thromb Hemost 2018;24:462-70. [PMID: 28110540 DOI: 10.1177/1076029616689593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
86 Zhang B, Jiang Z, Huang M, Zhu K, Qian J, Shan H. Effects of percutaneous transhepatic interventional treatment for symptomatic Budd-Chiari syndrome secondary to hepatic venous obstruction. Journal of Vascular Surgery: Venous and Lymphatic Disorders 2013;1:392-9. [DOI: 10.1016/j.jvsv.2013.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
87 Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling Pleural Catheters in Hepatic Hydrothorax: A Single-Center Series of Outcomes and Complications. Chest 2019;155:307-14. [PMID: 29990479 DOI: 10.1016/j.chest.2018.07.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
88 Agarwal AK, Gupta V, Singh S, Agarwal S, Sakhuja P. Management of patients of postcholecystectomy benign biliary stricture complicated by portal hypertension. Am J Surg 2008;195:421-6. [PMID: 18304509 DOI: 10.1016/j.amjsurg.2007.03.013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
89 Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Horacio JB, Rapier R, Vaida F, Hye RJ. Portal-systemic encephalopathy in a randomized controlled trial of endoscopic sclerotherapy versus emergency portacaval shunt treatment of acutely bleeding esophageal varices in cirrhosis. Ann Surg 2009;250:598-610. [PMID: 19730244 DOI: 10.1097/SLA.0b013e3181b73126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
90 Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, Niu J, Guo W, Luo B, Yin Z, Bai W, Chen H, Wang E, Xia D, Li X, Yuan J, Han N, Cai H, Li T, Xie H, Xia J, Wang J, Zhang H, Wu K, Fan D, Han G. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. Journal of Hepatology 2017;67:508-16. [DOI: 10.1016/j.jhep.2017.05.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 39] [Article Influence: 15.5] [Reference Citation Analysis]
91 Frontera JA. Management of hepatic encephalopathy. Curr Treat Options Neurol. 2014;16:297. [PMID: 24807164 DOI: 10.1007/s11940-014-0297-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
92 Cárdenas A, Ginès P. What’s new in the treatment of ascites and spontaneous bacterial peritonitis. Curr Gastroenterol Rep 2008;10:7-14. [DOI: 10.1007/s11894-008-0003-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
93 Qi X, Jia J, Bai M, Guo X, Su C, García-Pagán JC, Han G, Fan D. Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleeding: A Meta-analysis. J Clin Gastroenterol 2015;49:495-505. [PMID: 25127113 DOI: 10.1097/MCG.0000000000000205] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 3.4] [Reference Citation Analysis]
94 Reverter E, Blasi A, Abraldes JG, Martínez-Palli G, Seijo S, Turon F, Berzigotti A, Balust J, Bosch J, García-Pagán JC. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int 2014;34:16-25. [PMID: 23763484 DOI: 10.1111/liv.12229] [Cited by in Crossref: 30] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
95 Kaswala D, Gandhi D, Moroianu A, Patel J, Patel N, Klyde D, Brelvi Z. Hemobilia Secondary to Transjugular Intrahepatic Portosystemic Shunt Procedure: A Case Report. J Clin Med 2012;1:15-21. [PMID: 26237567 DOI: 10.3390/jcm1010015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
96 Changela K, Ona MA, Anand S, Duddempudi S. Self-Expanding Metal Stent (SEMS): an innovative rescue therapy for refractory acute variceal bleeding. Endosc Int Open 2014;2:E244-51. [PMID: 26135101 DOI: 10.1055/s-0034-1377980] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
97 Feyssa E, Ortiz J, Grewal K, Azhar A, Parsikia A, Tufail K, Hashemi N, Brady P, Araya V. MELD score less than 15 predicts prolonged survival after transjugular intrahepatic portosystemic shunt for refractory ascites after liver transplantation. Transplantation. 2011;91:786-792. [PMID: 21304440 DOI: 10.1097/tp.0b013e31820e014e] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
98 Sharma P, Sarin SK. Improved survival with the patients with variceal bleed. Int J Hepatol. 2011;2011:356919. [PMID: 21994853 DOI: 10.4061/2011/356919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
99 Casadaban LC, Parvinian A, Couture PM, Minocha J, Knuttinen MG, Bui JT, Gaba RC. Characterization of Liver Function Parameter Alterations After Transjugular Intrahepatic Portosystemic Shunt Creation and Association With Early Mortality. American Journal of Roentgenology 2014;203:1363-70. [DOI: 10.2214/ajr.13.12232] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
100 Krige JEJ, Shaw JM, Bornman PC. The Evolving Role of Endoscopic Treatment for Bleeding Esophageal Varices. World J Surg 2005;29:966-73. [DOI: 10.1007/s00268-005-0138-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
101 Orloff MJ, Isenberg JI, Wheeler HO, Haynes KS, Jinich-Brook H, Rapier R, Vaida F, Hye RJ, Orloff SL. Liver transplantation in a randomized controlled trial of emergency treatment of acutely bleeding esophageal varices in cirrhosis. Transplant Proc. 2010;42:4101-4108. [PMID: 21168637 DOI: 10.1016/j.transproceed.2010.09.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
102 Medsinge A, Zajko A, Orons P, Amesur N, Santos E. A case-based approach to common embolization agents used in vascular interventional radiology. AJR Am J Roentgenol. 2014;203:699-708. [PMID: 25247933 DOI: 10.2214/ajr.14.12480] [Cited by in Crossref: 28] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
103 Verbeeck S, Mekhali D, Cassiman D, Maleux G, Witters P. Long-term outcome of transjugular intrahepatic portosystemic shunt for portal hypertension in autosomal recessive polycystic kidney disease. Dig Liver Dis 2018;50:707-12. [PMID: 29622386 DOI: 10.1016/j.dld.2018.03.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
104 Holden A, Ng R, Gane E, Hill A, McCall J. A technique for controlled partial closure of a transjugular intrahepatic portosystemic shunt tract in a patient with hepatic encephalopathy. J Vasc Interv Radiol. 2006;17:1957-1961. [PMID: 17185693 DOI: 10.1097/01.RVI.0000244850.39439.34] [Cited by in Crossref: 11] [Article Influence: 0.8] [Reference Citation Analysis]
105 Smith JC, Black MD, Mendler MH. Concomitant Hepatic Encephalopathy and Refractory Ascites: Successful Treatment with Staged Embolization of Two Large Portosystemic Shunts and Transjugular Intrahepatic Portosystemic Shunt Placement. Journal of Vascular and Interventional Radiology 2007;18:1441-6. [DOI: 10.1016/j.jvir.2007.07.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
106 Jafri S, Gordon SC. Care of the Cirrhotic Patient. Infectious Disease Clinics of North America 2012;26:979-94. [DOI: 10.1016/j.idc.2012.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
107 Sampaio MS, Martin P, Bunnapradist S. Renal dysfunction in end-stage liver disease and post-liver transplant. Clin Liver Dis 2014;18:543-60. [PMID: 25017075 DOI: 10.1016/j.cld.2014.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
108 Corbett C, Murphy N, Olliff S, Mangat KS, Tripathi D. A case-control study of transjugular intrahepatic portosystemic stent shunts for patients admitted to intensive care following variceal bleeding. Eur J Gastroenterol Hepatol. 2013;25:344-351. [PMID: 23354162 DOI: 10.1097/MEG.0b013e32835aa414] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Khosa S, Auckley D. Occult massive hemorrhage in a patient with cirrhosis. Ann Am Thorac Soc 2013;10:160-2. [PMID: 23607850 DOI: 10.1513/AnnalsATS.201212-117CR] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
110 La Mura V, Abraldes JG, Berzigotti A, Erice E, Flores-Arroyo A, García-Pagán JC, Bosch J. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study. Hepatology. 2010;51:2108-2116. [PMID: 20512998 DOI: 10.1002/hep.23612] [Cited by in Crossref: 55] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
111 Caly WR, Abreu RM, Bitelman B, Carrilho FJ, Ono SK. Clinical Features of Refractory Ascites in Outpatients. Clinics (Sao Paulo). 2017;72:405-410. [PMID: 28792999 DOI: 10.6061/clinics/2017(07)03] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
112 Dechêne A, El Fouly AH, Bechmann LP, Jochum C, Saner FH, Gerken G, Canbay A. Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion 2012;85:185-91. [PMID: 22269340 DOI: 10.1159/000335081] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
113 Wang Y, Qiao D, Li Y, Xu F. Risk factors for hepatic veno-occlusive disease caused by Gynura segetum: a retrospective study. BMC Gastroenterol. 2018;18:156. [PMID: 30367628 DOI: 10.1186/s12876-018-0879-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
114 Faccia M, Ainora ME, Ponziani FR, Riccardi L, Garcovich M, Gasbarrini A, Pompili M, Zocco MA. Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate. World J Gastroenterol. 2019;25:4437-4451. [PMID: 31496623 DOI: 10.3748/wjg.v25.i31.4437] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 20.0] [Reference Citation Analysis]
115 Van Thiel DH, Moore CM, Garcia M, George M, Nadir A. Continuous peritoneal drainage of large-volume ascites. Dig Dis Sci. 2011;56:2723-2727. [PMID: 21735084 DOI: 10.1007/s10620-011-1792-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
116 Banini BA, Alwatari Y, Stovall M, Ogden N, Gershman E, Shah RD, Strife BJ, Shojaee S, Sterling RK. Multidisciplinary Management of Hepatic Hydrothorax in 2020: An Evidence-Based Review and Guidance. Hepatology 2020;72:1851-63. [PMID: 32585037 DOI: 10.1002/hep.31434] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
117 Shi H, Cao A, Chen J, Deng G, Teng G. Transjugular Intrahepatic Portosystemic Shunt with an Autologous Endothelial Progenitor Cell Seeded Stent:. Academic Radiology 2010;17:358-67. [DOI: 10.1016/j.acra.2009.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
118 Saad WE. The history and future of transjugular intrahepatic portosystemic shunt: food for thought. Semin Intervent Radiol. 2014;31:258-261. [PMID: 25177087 DOI: 10.1055/s-0034-1382794] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
119 Sabri SS, Swee W, Turba UC, Saad WE, Park AW, Al-osaimi AM, Caldwell SH, Matsumoto AH, Angle JF. Bleeding Gastric Varices Obliteration with Balloon-occluded Retrograde Transvenous Obliteration Using Sodium Tetradecyl Sulfate Foam. Journal of Vascular and Interventional Radiology 2011;22:309-16. [DOI: 10.1016/j.jvir.2010.11.022] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 7.2] [Reference Citation Analysis]
120 Dai N, Yu YC, Ren TH, Wu JG, Jiang Y, Shen LG, Zhang J. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J Gastroenterol 2007;13:1628-31. [PMID: 17461462 DOI: 10.3748/wjg.v13.i10.1628] [Cited by in CrossRef: 64] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
121 Pateria P, Jeffrey GP, Garas G, Tibballs J, Ferguson J, Delriviere L, Huang Y, Adams LA, Macquillan G. Transjugular intrahepatic portosystemic shunt: Indications, complications, survival and its use as a bridging therapy to liver transplant in Western Australia. J Med Imaging Radiat Oncol 2017;61:441-7. [DOI: 10.1111/1754-9485.12563] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
122 Fleming JN, Abou Abbass A. Hepatorenal syndrome: a comprehensive overview for the critical care nurse. Crit Care Nurs Clin North Am 2010;22:351-68. [PMID: 20691386 DOI: 10.1016/j.ccell.2010.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
123 Ferrarese A, Passigato N, Cusumano C, Gemini S, Tonon A, Dajti E, Marasco G, Ravaioli F, Colecchia A. Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice. WJH 2021;13:840-52. [DOI: 10.4254/wjh.v13.i8.840] [Reference Citation Analysis]
124 Casadaban LC, Parvinian A, Zivin SP, Lakhoo J, Minocha J, Knuttinen MG, Ray CE, Bui JT, Gaba RC. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Annals of Hepatology 2015;14:380-8. [DOI: 10.1016/s1665-2681(19)31278-5] [Cited by in Crossref: 19] [Article Influence: 3.2] [Reference Citation Analysis]
125 Lodato F, Berzigotti A, Lisotti A, Azzaroli F, Mosconi C, Giampalma E, Renzulli M, Cappelli A, Buonfiglioli F, Calvanese C, Zoli M, Golfieri R, Mazzella G. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience. Scandinavian Journal of Gastroenterology 2012;47:1494-500. [DOI: 10.3109/00365521.2012.703239] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
126 Lo GH. Prevention of esophageal variceal rebleeding. J Chin Med Assoc. 2006;69:553-560. [PMID: 17182347 DOI: 10.1016/s1726-4901(09)70328-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
127 Ferral H. The evaluation of the patient undergoing an elective transjugular intrahepatic portosystemic shunt procedure. Semin Intervent Radiol. 2005;22:266-270. [PMID: 21326704 DOI: 10.1055/s-2005-925552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
128 Gómez-Hurtado I, Such J, Sanz Y, Francés R. Gut microbiota-related complications in cirrhosis. World J Gastroenterol. 2014;20:15624-15631. [PMID: 25400446 DOI: 10.3748/wjg.v20.i42.15624] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
129 Agrawal S, Umapathy S, Dhiman RK. Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol. 2015;5:S42-S48. [PMID: 26041957 DOI: 10.1016/j.jceh.2014.11.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
130 Goh GB, Schauer PR, McCullough AJ. Considerations for bariatric surgery in patients with cirrhosis. World J Gastroenterol 2018;24:3112-9. [PMID: 30065557 DOI: 10.3748/wjg.v24.i28.3112] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
131 Suk KT, Baik SK, Yoon JH, Cheong JY, Paik YH, Lee CH, Kim YS, Lee JW, Kim DJ, Cho SW, Hwang SG, Sohn JH, Kim MY, Kim YB, Kim JG, Cho YK, Choi MS, Kim HJ, Lee HW, Kim SU, Kim JK, Choi JY, Jun DW, Tak WY, Lee BS, Jang BK, Chung WJ, Kim HS, Jang JY, Jeong SW, Kim SG, Kwon OS, Jung YK, Choe WH, Lee JS, Kim IH, Shim JJ, Cheon GJ, Bae SH, Seo YS, Choi DH, Jang SJ; Korean Association for the Study of the Liver. Revision and update on clinical practice guideline for liver cirrhosis. Korean J Hepatol. 2012;18:1-21. [PMID: 22511898 DOI: 10.3350/kjhep.2012.18.1.1] [Cited by in Crossref: 94] [Cited by in F6Publishing: 81] [Article Influence: 10.4] [Reference Citation Analysis]
132 Opio CK, Garcia-tsao G. Managing Varices: Drugs, Bands, and Shunts. Gastroenterology Clinics of North America 2011;40:561-79. [DOI: 10.1016/j.gtc.2011.06.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
133 Kim JJ, Dasika NL, Yu E, Fontana RJ. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery. J Clin Gastroenterol. 2009;43:574-579. [PMID: 19169145 DOI: 10.1097/mcg.0b013e31818738ef] [Cited by in Crossref: 48] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
134 Park C, Patel YA, Suhocki P, Dorsey C, Kapila N, Tang L, Gilner J. High-risk third trimester pregnancy with decompensated cirrhosis safely delivered following emergent preoperative interventional radiology for mitigation of variceal bleeding. Clin Imaging 2020;68:143-7. [PMID: 32615516 DOI: 10.1016/j.clinimag.2020.06.032] [Reference Citation Analysis]
135 Amarapurkar DN, Punamiya S, Patel ND. An experience with covered transjugular intrahepatic portosystemic shunt for refractory ascites from western India. Annals of Hepatology 2006;5:103-8. [DOI: 10.1016/s1665-2681(19)32026-5] [Cited by in Crossref: 6] [Article Influence: 0.4] [Reference Citation Analysis]
136 Møller S, Krag A, Henriksen JH, Bendtsen F. Pathophysiological aspects of pulmonary complications of cirrhosis. Scandinavian Journal of Gastroenterology 2009;42:419-27. [DOI: 10.1080/00365520601151695] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
137 Moller S, Henriksen JH. Cardiopulmonary complications in chronic liver disease. World J Gastroenterol 2006;12:526-38. [PMID: 16489664 DOI: 10.3748/wjg.v12.i4.526] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
138 Waguri N, Osaki A, Ikarashi S, Ogawa M, Kuraoka N, Ogawa K, Sato M, Aiba T, Yoneyama O, Furukawa K, Sugimura K, Igarashi K. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for gastric fundal varices. United European Gastroenterol J. 2016;4:62-69. [PMID: 26966524 DOI: 10.1177/2050640615581966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
139 Ćwikiel W. Interventional procedures involving portal vein circulation: a review. Acta Radiol 2006;47:145-56. [DOI: 10.1080/02841850500466567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
140 DellaVolpe J, Al-Khafaji A. Acute Kidney Injury Before and After Liver Transplant. J Intensive Care Med. 2019;34:687-695. [PMID: 30060683 DOI: 10.1177/0885066618790558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
141 Imai Y, Nakazawa M, Ando S, Sugawara K, Hamaoka K, Oka M, Mochida S. Balloon-occluded retrograde transvenous obliteration using a microballoon catheter for intractable gastric fundal varices. J Gastroenterol Hepatol 2014;29:365-71. [PMID: 23927078 DOI: 10.1111/jgh.12351] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
142 Imai Y, Nakazawa M, Ando S, Sugawara K, Mochida S. Long-term outcome of 154 patients receiving balloon-occluded retrograde transvenous obliteration for gastric fundal varices: Balloon-occluded retrograde transvenous obliteration. Journal of Gastroenterology and Hepatology 2016;31:1844-50. [DOI: 10.1111/jgh.13382] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
143 Mahgerefteh SY, Sosna J, Bogot N, Shapira MY, Pappo O, Bloom AI. Radiologic Imaging and Intervention for Gastrointestinal and Hepatic Complications of Hematopoietic Stem Cell Transplantation. Radiology 2011;258:660-71. [DOI: 10.1148/radiol.10100025] [Cited by in Crossref: 66] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
144 Dib N, Oberti F, Calès P. Current management of the complications of portal hypertension: variceal bleeding and ascites. CMAJ 2006;174:1433-43. [PMID: 16682712 DOI: 10.1503/cmaj.051700] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
145 Weber CN, Nadolski GJ, White SB, Clark TW, Mondschein JI, Stavropoulos SW, Shlansky-Goldberg RD, Trerotola SO, Soulen MC. Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. J Vasc Interv Radiol. 2015;26:1257-65; quiz 1265. [PMID: 25990133 DOI: 10.1016/j.jvir.2015.04.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
146 Lau C, Martin P, Bunnapradist S. Management of renal dysfunction in patients receiving a liver transplant. Clin Liver Dis 2011;15:807-20. [PMID: 22032530 DOI: 10.1016/j.cld.2011.08.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
147 Poordad FF. Review article: the burden of hepatic encephalopathy. Aliment Pharmacol Ther. 2007;25 Suppl 1:3-9. [PMID: 17295846 DOI: 10.1111/j.1746-6342.2006.03215.x] [Cited by in Crossref: 238] [Cited by in F6Publishing: 179] [Article Influence: 17.0] [Reference Citation Analysis]
148 Jain D, Mahmood E, V-Bandres M, Feyssa E. Preoperative elective transjugular intrahepatic portosystemic shunt for cirrhotic patients undergoing abdominal surgery. Ann Gastroenterol 2018;31:330-7. [PMID: 29720858 DOI: 10.20524/aog.2018.0249] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
149 Chalhoub M, Harris K, Castellano M, Maroun R, Bourjeily G. The use of the PleurX catheter in the management of non-malignant pleural effusions. Chron Respir Dis 2011;8:185-91. [PMID: 21636653 DOI: 10.1177/1479972311407216] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
150 Guerrini GP, Pleguezuelo M, Maimone S, Calvaruso V, Xirouchakis E, Patch D, Rolando N, Davidson B, Rolles K, Burroughs A. Impact of tips preliver transplantation for the outcome posttransplantation. Am J Transplant. 2009;9:192-200. [PMID: 19067664 DOI: 10.1111/j.1600-6143.2008.02472.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 3.2] [Reference Citation Analysis]
151 Young S, Bermudez J, Zhang L, Rostambeigi N, Golzarian J. Transjugular intrahepatic portosystemic shunt (TIPS) placement: A comparison of outcomes between patients with hepatic hydrothorax and patients with refractory ascites. Diagnostic and Interventional Imaging 2019;100:303-8. [DOI: 10.1016/j.diii.2018.10.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
152 Nguyen C, Robinson T, Borgmann AJ, Baron C, Imani RA. A method for revision of a foreshortened transjugular intrahepatic portosystemic shunt (TIPS) stent using transhepatic trans-stent access. Radiol Case Rep 2021;16:2376-81. [PMID: 34306285 DOI: 10.1016/j.radcr.2021.06.019] [Reference Citation Analysis]
153 Tsauo J, Noh SY, Shin JH, Gwon DI, Han K, Lee JM, Jeon UB, Kim YH. Retrograde transvenous obliteration for the prevention of variceal rebleeding in patients with hepatocellular carcinoma: a multicentre retrospective study. Clin Radiol 2021;76:681-7. [PMID: 34140137 DOI: 10.1016/j.crad.2021.05.011] [Reference Citation Analysis]
154 Tripathi D, Redhead D. Transjugular intrahepatic portosystemic stent-shunt: technical factors and new developments. Eur J Gastroenterol Hepatol. 2006;18:1127-1133. [PMID: 17033430 DOI: 10.1097/01.meg.0000236871.78280.a7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
155 Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC. Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut. 2006;55:1617-1623. [PMID: 16571635 DOI: 10.1136/gut.2005.089482] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
156 Chen RP, Zhu Ge XJ, Huang ZM, Ye XH, Hu CY, Lu GR, Lu de Y, Phemba IL. Prophylactic use of transjugular intrahepatic portosystemic shunt aids in the treatment of refractory ascites: metaregression and trial sequential meta-analysis. J Clin Gastroenterol. 2014;48:290-299. [PMID: 24030734 DOI: 10.1097/mcg.0b013e3182a115e9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
157 Bucsics T, Schoder M, Diermayr M, Feldner-Busztin M, Goeschl N, Bauer D, Schwabl P, Mandorfer M, Angermayr B, Cejna M, Ferlitsch A, Sieghart W, Trauner M, Peck-Radosavljevic M, Karner J, Karnel F, Reiberger T. Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experience. PLoS One 2018;13:e0189414. [PMID: 29315304 DOI: 10.1371/journal.pone.0189414] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
158 Saxena P, Lakhtakia S. Endoscopic ultrasound guided vascular access and therapy (with videos). Endosc Ultrasound. 2015;4:168-175. [PMID: 26374574 DOI: 10.4103/2303-9027.162994] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
159 Waguri N, Osaki A, Watanabe Y. Balloon-occluded retrograde transvenous obliteration for treatment of gastric varices. World J Hepatol 2021;13:650-61. [PMID: 34239700 DOI: 10.4254/wjh.v13.i6.650] [Reference Citation Analysis]
160 Schepis F, Vizzutti F, Garcia-Tsao G, Marzocchi G, Rega L, De Maria N, Di Maira T, Gitto S, Caporali C, Colopi S, De Santis M, Arena U, Rampoldi A, Airoldi A, Cannavale A, Fanelli F, Mosconi C, Renzulli M, Agazzi R, Nani R, Quaretti P, Fiorina I, Moramarco L, Miraglia R, Luca A, Bruno R, Fagiuoli S, Golfieri R, Torricelli P, Di Benedetto F, Belli LS, Banchelli F, Laffi G, Marra F, Villa E. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2018;16:1153-1162.e7. [PMID: 29378312 DOI: 10.1016/j.cgh.2018.01.029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 12.7] [Reference Citation Analysis]
161 Qi XS, Bai M, Yang ZP, Fan DM. Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. World J Gastroenterol. 2014;20:6470-6480. [PMID: 24914368 DOI: 10.3748/wjg.v20.i21.6470] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
162 Matsushita Y, Narahara Y, Fujimori S, Kanazawa H, Itokawa N, Fukuda T, Takahashi Y, Kondo C, Kidokoro H, Atsukawa M. Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension. J Gastroenterol. 2013;48:633-639. [PMID: 22968470 DOI: 10.1007/s00535-012-0660-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
163 Bureau C. Covered stents for TIPS: are all problems solved? Eur J Gastroenterol Hepatol 2006;18:581-3. [PMID: 16702844 DOI: 10.1097/00042737-200606000-00001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
164 Maschke SK, Werncke T, Renne J, Kloeckner R, Marquardt S, Kirstein MM, Potthoff A, Wacker FK, Meyer BC, Hinrichs JB. Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction: quantitative assessment of flow and perfusion changes using 2D-perfusion angiography following shunt revision. Abdom Radiol 2018;43:2868-75. [DOI: 10.1007/s00261-018-1547-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
165 Cárdenas A, Ginès P. Management of Refractory Ascites. Clinical Gastroenterology and Hepatology 2005;3:1187-91. [DOI: 10.1016/s1542-3565(05)00861-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
166 Lim LG, Lee YM, Tan L, Chang S, Lim SG. Percutaneous paraumbilical embolization as an unconventional and successful treatment for bleeding jejunal varices. World J Gastroenterol 2009;15:3823-6. [PMID: 19673028 DOI: 10.3748/wjg.15.3823] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
167 Sharma A, Keshava SN, Eapen A, Elias E, Eapen CE. An Update on the Management of Budd-Chiari Syndrome. Dig Dis Sci 2021;66:1780-90. [PMID: 32691382 DOI: 10.1007/s10620-020-06485-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 López-méndez E, Chávez-tapia NC, Avila-escobedo L, Cabrera-aleksandrova T, Uribe M. Early experience of Budd-Chiari syndrome treatment with transjugular intrahepatic portosystemic shunt. Annals of Hepatology 2006;5:157-60. [DOI: 10.1016/s1665-2681(19)31999-4] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
169 Lo GH. The role of endoscopy in secondary prophylaxis of esophageal varices. Clin Liver Dis 2010;14:307-23. [PMID: 20682237 DOI: 10.1016/j.cld.2010.03.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
170 Maufa F, Al-Kawas FH. Role of self-expandable metal stents in acute variceal bleeding. Int J Hepatol. 2012;2012:418369. [PMID: 22928113 DOI: 10.1155/2012/418369] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
171 Bai M, He C, Yin Z, Niu J, Wang Z, Qi X, Liu L, Yang Z, Guo W, Tie J, Bai W, Xia J, Cai H, Wang J, Wu K, Fan D, Han G. Randomised clinical trial: l -ornithine- l -aspartate reduces significantly the increase of venous ammonia concentration after TIPSS. Aliment Pharmacol Ther 2014;40:63-71. [DOI: 10.1111/apt.12795] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
172 Gaba RC, Parvinian A, Minocha J, Casadaban LC, Knuttinen MG, Ray CE, Bui JT. Should transjugular intrahepatic portosystemic shunt stent grafts be underdilated? J Vasc Interv Radiol. 2015;26:382-387. [PMID: 25735521 DOI: 10.1016/j.jvir.2014.08.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
173 Copelan A, Kapoor B, Sands M. Transjugular intrahepatic portosystemic shunt: indications, contraindications, and patient work-up. Semin Intervent Radiol. 2014;31:235-242. [PMID: 25177083 DOI: 10.1055/s-0034-1382790] [Cited by in Crossref: 48] [Cited by in F6Publishing: 24] [Article Influence: 6.9] [Reference Citation Analysis]
174 Singal AK, Kathuria MK, Malhotra A, Goodgame RW, Soloway RD. Bilhemia after trans-jugular intra-hepatic porto-systemic shunt and its management with biliary decompression. World J Gastroenterol 2009;15:3681-3. [PMID: 19653349 DOI: 10.3748/wjg.15.3681] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
175 Caporossi J, Vidal V, Jacquier A, Reyre A, Flavian A, Muller C, Gaubert J, Bartoli J, Moulin G, Varoquaux A. Balloon occlusion versus wedged hepatic venography using iodinated contrast for targeting the portal vein during TIPS. Diagnostic and Interventional Imaging 2015;96:357-63. [DOI: 10.1016/j.diii.2014.11.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
176 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
177 Sussman AN, Boyer TD. Management of refractory ascites and hepatorenal syndrome. Curr Gastroenterol Rep 2011;13:17-25. [PMID: 21080246 DOI: 10.1007/s11894-010-0156-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
178 Qi X, Yang M, Fan D, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of Budd-Chiari syndrome: a critical review of literatures. Scand J Gastroenterol. 2013;48:771-784. [PMID: 23506234 DOI: 10.3109/00365521.2013.777775] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
179 Senzolo M, Cholongitas E, Patch D, Burroughs AK. TIPS for veno-occlusive disease: is the contraindication real? Hepatology. 2005;42:240-241; author reply 241. [PMID: 15962296 DOI: 10.1002/hep.20773] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
180 Waguri N, Hayashi M, Yokoo T, Sato R, Arao Y, Setsu T, Sato M, Kohisa J, Hama I, Ohsugi K, Aiba T, Yoneyama O, Furukawa K, Sugimura K, Igarashi K, Suda T. Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for portosystemic shunts. J Vasc Interv Radiol. 2012;23:650-657. [PMID: 22459878 DOI: 10.1016/j.jvir.2012.01.065] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
181 Bosch J, Abraldes JG, Albillos A, Aracil C, Bañares R, Berzigotti A, Calleja JL, de la Peña J, Escorsell A, García-pagán JC, Genescà J, Hernández-guerra M, Ripoll C, Planas R, Villanueva C. Hipertensión portal: recomendaciones para su evaluación y tratamiento. Gastroenterología y Hepatología 2012;35:421-50. [DOI: 10.1016/j.gastrohep.2012.02.009] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
182 Iversen P, Keiding S, Mouridsen K, Ott P, Vilstrup H. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow. Clin Gastroenterol Hepatol 2011;9:1001-3. [PMID: 21806953 DOI: 10.1016/j.cgh.2011.07.015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
183 Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol. 2009;104:2458-2466. [PMID: 19532126 DOI: 10.1038/ajg.2009.321] [Cited by in Crossref: 119] [Cited by in F6Publishing: 90] [Article Influence: 9.9] [Reference Citation Analysis]
184 Shao XD, Qi XS, Guo XZ. Esophageal Stent for Refractory Variceal Bleeding: A Systemic Review and Meta-Analysis. Biomed Res Int. 2016;2016:4054513. [PMID: 27517043 DOI: 10.1155/2016/4054513] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
185 Boyer TD, Henderson JM, Heerey AM, Arrigain S, Konig V, Connor J, Abu-Elmagd K, Galloway J, Rikkers LF, Jeffers L; DIVERT Study Group. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 2008;48:407-14. [PMID: 18045724 DOI: 10.1016/j.jhep.2007.08.014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
186 Bai M, Qi X, Yang Z, Yin Z, Nie Y, Yuan S, Wu K, Han G, Fan D. Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review. J Gastroenterol Hepatol. 2011;26:943-951. [PMID: 21251067 DOI: 10.1111/j.1440-1746.2011.06663.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 73] [Article Influence: 9.7] [Reference Citation Analysis]
187 Bavdekar A, Thakur N. Ascites in Children. Indian J Pediatr 2016;83:1334-40. [DOI: 10.1007/s12098-016-2168-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
188 Garcia-Tsao G. Portal hypertension. Curr Opin Gastroenterol. 2006;22:254-262. [PMID: 16550040 DOI: 10.1097/01.mog.0000218962.93806.9a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
189 Hobolth L, Krag A, Bendtsen F. The recent reduction in mortality from bleeding oesophageal varices is primarily observed from Days 1 to 5. Liver Int. 2010;30:455-462. [PMID: 19968778 DOI: 10.1111/j.1478-3231.2009.02169.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
190 Perarnau JM, Baju A, D'alteroche L, Viguier J, Ayoub J. Feasibility and long-term evolution of TIPS in cirrhotic patients with portal thrombosis. Eur J Gastroenterol Hepatol. 2010;22:1093-1098. [PMID: 20308910 DOI: 10.1097/meg.0b013e328338d995] [Cited by in Crossref: 67] [Cited by in F6Publishing: 21] [Article Influence: 6.1] [Reference Citation Analysis]
191 Colombato L. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. J Clin Gastroenterol. 2007;41 Suppl 3:S344-S351. [PMID: 17975487 DOI: 10.1097/mcg.0b013e318157e500] [Cited by in Crossref: 90] [Cited by in F6Publishing: 28] [Article Influence: 6.9] [Reference Citation Analysis]
192 Orloff MJ, Vaida F, Haynes KS, Hye RJ, Isenberg JI, Jinich-Brook H. Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg 2012;16:2094-111. [PMID: 23007280 DOI: 10.1007/s11605-012-2003-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
193 Sabri SS, Saad WE. Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Technique and Intraprocedural Imaging. Semin Intervent Radiol 2011;28:303-13. [PMID: 22942548 DOI: 10.1055/s-0031-1284457] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
194 Sabri SS, Abi-Jaoudeh N, Swee W, Saad WE, Turba UC, Caldwell SH, Angle JF, Matsumoto AH. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt vs balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol. 2014;25:355-361. [PMID: 24468043 DOI: 10.1016/j.jvir.2013.12.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
195 LaBerge JM. Transjugular intrahepatic portosystemic shunt--role in treating intractable variceal bleeding, ascites, and hepatic hydrothorax. Clin Liver Dis 2006;10:583-98, ix. [PMID: 17162229 DOI: 10.1016/j.cld.2006.08.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
196 Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int. 2012;6:576-590. [PMID: 26201472 DOI: 10.1007/s12072-011-9324-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
197 Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci 2016;12:1381-3. [PMID: 27904533 DOI: 10.5114/aoms.2016.62921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
198 Koh C, Zhao X, Samala N, Sakiani S, Liang TJ, Talwalkar JA. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations. Hepatology 2013;58:2142-52. [PMID: 23775835 DOI: 10.1002/hep.26578] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
199 Lauermann J, Potthoff A, Mc Cavert M, Marquardt S, Vaske B, Rosenthal H, von Hahn T, Wacker F, Meyer BC, Rodt T. Comparison of Technical and Clinical Outcome of Transjugular Portosystemic Shunt Placement Between a Bare Metal Stent and a PTFE-Stentgraft Device. Cardiovasc Intervent Radiol 2016;39:547-56. [DOI: 10.1007/s00270-015-1209-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
200 Qi X, He C, Yin Z, Wang Z, Zhang H, Yao L, Wang J, Xia J, Cai H, Yang Z, Bai M, Guo W, Niu J, Wu K, Fan D, Han G; PVT-TIPS Study Group. Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial. BMJ Open 2013;3:e003370. [PMID: 23847271 DOI: 10.1136/bmjopen-2013-003370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
201 Velamati PG, Herlong HF. Treatment of refractory ascites. Curr Treat Options Gastro 2006;9:530-7. [DOI: 10.1007/s11938-006-0009-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
202 Moore CM, Van Thiel DH. Cirrhotic ascites review: Pathophysiology, diagnosis and management. World J Hepatol. 2013;5:251-263. [PMID: 23717736 DOI: 10.4254/wjh.v5.i5.251] [Cited by in Crossref: 56] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
203 Guy J, Somsouk M, Shiboski S, Kerlan R, Inadomi JM, Biggins SW. New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt. Clin Gastroenterol Hepatol 2009;7:1236-40. [PMID: 19560557 DOI: 10.1016/j.cgh.2009.06.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
204 Mondal P, Trigun SK. Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy. Metab Brain Dis 2014;29:1007-15. [DOI: 10.1007/s11011-014-9556-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
205 Khungar V, Poordad F. Hepatic encephalopathy. Clin Liver Dis. 2012;16:301-320. [PMID: 22541700 DOI: 10.1016/j.cld.2011.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
206 Liu J, Ma J, Zhou C, Yang C, Huang S, Shi Q, Xiong B. Potential Benefits of Underdilation of 8-mm Covered Stent in Transjugular Intrahepatic Portosystemic Shunt Creation. Clin Transl Gastroenterol 2021;12:e00376. [PMID: 34140457 DOI: 10.14309/ctg.0000000000000376] [Reference Citation Analysis]
207 Garcia-tsao G, Sanyal AJ, Grace ND, Carey WD; the Practice Guidelines Committee of the American Association for the Study of Liver Diseases and the Practice Parameters Committee of the American College of Gastroenterology. Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis. Am J Gastroenterology 2007;102:2086-102. [DOI: 10.1111/j.1572-0241.2007.01481.x] [Cited by in Crossref: 219] [Cited by in F6Publishing: 154] [Article Influence: 15.6] [Reference Citation Analysis]
208 Choe WH. Do cirrhotic patients with a high MELD score benefit from TIPS? Clin Mol Hepatol 2014;20:15-7. [PMID: 24757654 DOI: 10.3350/cmh.2014.20.1.15] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
209 Ibukuro K, Kojima K, Kigawa I, Tanaka R, Fukuda H, Abe S, Tobe K, Tagawa K. Embolization of rectal varices via a paraumbilical vein with an abdominal wall approach in a patient with massive ascites. J Vasc Interv Radiol. 2009;20:1259-1261. [PMID: 19729137 DOI: 10.1016/j.jvir.2009.05.041] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
210 Zhang Y, Liu FQ, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL. Safety and efficacy of transfemoral intrahepatic portosystemic shunt for portal hypertension: A single-center retrospective study. World J Clin Cases 2019;7:1410-20. [PMID: 31363469 DOI: 10.12998/wjcc.v7.i12.1410] [Reference Citation Analysis]
211 Therapondos G, Wong F. Miscellaneous indications for transjugular intrahepatic portosystemic stent-shunt: . European Journal of Gastroenterology & Hepatology. [DOI: 10.1097/01.meg.0000236876.60354.25] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
212 Boyer TD, Haskal ZJ;  American Association for the Study of Liver Diseases. The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in the Management of Portal Hypertension: update 2009. Hepatology. 2010;51:306. [PMID: 19902484 DOI: 10.1002/hep.23383] [Cited by in Crossref: 339] [Cited by in F6Publishing: 253] [Article Influence: 30.8] [Reference Citation Analysis]
213 Kamath PS, Kim WR; Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD). Hepatology. 2007;45:797-805. [PMID: 17326206 DOI: 10.1002/hep.21563] [Cited by in Crossref: 914] [Cited by in F6Publishing: 751] [Article Influence: 65.3] [Reference Citation Analysis]
214 Binmoeller KF, Sendino O, Kane SD. Endoscopic ultrasound-guided intravascular therapy. J Hepatobiliary Pancreat Sci 2015;22:44-50. [PMID: 25366271 DOI: 10.1002/jhbp.183] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
215 Anastasiou J, Berzin TM. Endoscopic Ultrasound-Guided Vascular Interventions: From Diagnosis to Treatment. Saudi J Med Med Sci. 2018;6:61-67. [PMID: 30787823 DOI: 10.4103/sjmms.sjmms_131_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]